APVO Aptevo Therapeutics
- 0.890
- -0.045-4.81%
Aptevo Therapeutics News
Aptevo Therapeutics Q1 EPS $(9.95) Beats $(12.84) Estimate
Aptevo Therapeutics (NASDAQ:APVO) reported quarterly losses of $(9.95) per share which beat the analyst consensus estimate of $(12.84) by 22.51 percent. This is a 76.92 percent increase over losses of
Aptevo Therapeutics | 10-Q: Quarterly report
Aptevo Therapeutics Reports 1Q 2024 Financial Results and Provides a Business Update
ptevo Therapeutics Inc. (NASDAQ:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today reported financial results for the quarter ended March 31, 2024 and provided a business update.
12 Health Care Stocks Moving In Friday's After-Market Session
GainersNeuBase Therapeutics (NASDAQ:NBSE) stock increased by 11.1% to $0.45 during Friday's after-market session. The market value of their outstanding shares is at $1.6 million. Aptevo Therapeutics (
Aptevo Therapeutics (APVO) Sees Spectacular Rise Push on to Pre-market Session
Aptevo Therapeutics Inc. (NASDAQ: APVO) experienced a whirlwind of activity on Wednesday, with its stock soaring an impressive 35%. Yet, the excitement didn't stop there. In the early premarket hours on Thursday, APVO witnessed an additional staggering leap of 49%, reaching a high of $1.43. What's Driving the Surge? Despite the lack of apparent news ...
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
Shares of Aspen Aerogels, Inc. (NYSE:ASPN) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results.Aspen Aerogels posted a GAAP loss
US Equity Markets Close Mixed After March Producer Price Inflation Data
US equity markets closed mixed Thursday following the wholesale producer price inflation data for March. * The US producer price index increased 2.1% year-over-year in March, accelerating from 1.6% in
Why Aptevo Therapeutics Stock Is Cratering
Aptevo Therapeutics Inc. (NASDAQ:APVO) shares are trading lower Thursday after the company priced its $4.6 million public offering.The Details:Aptevo announced the pricing of a public offering of 3,40
Top Midday Decliners
Aptevo Therapeutics (APVO) said it priced a public offering of 3.4 million shares and warrants to purchase up to 6.8 million shares at $1.35 a share and associated common warrant, targeting gross proc
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of Fastenal Company (NASDAQ:FAST) fell sharply during Thursday's session following worse-than-expected first-quarter financial results. Fastenal reported first-quarter FY24 sales growth of 1.9
NKTR, VERU and EGIO Among Mid-day Movers
Dow Dips 100 Points; CarMax Earnings Miss Views
U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 100 points on Thursday. The Dow traded down 0.35% to 38,328.18 while the NASDAQ rose 0.50% to 16,251.71. The S&
Enlivex Therapeutics, Nyxoah SA, China SXT Pharmaceuticals Among Healthcare Movers
Nasdaq Gains Over 50 Points; US Producer Prices Increase In March
U.S. stocks traded mostly higher this morning, following the release of PPI data. Following the market opening Thursday, the Dow traded up 0.03% to 38,472.80 while the NASDAQ rose 0.40% to 16,234.94.
Aptevo Therapeutics (APVO) Faces Sharp Decline in Premarket Trading
Aptevo Therapeutics Inc. (NASDAQ: APVO) experienced a tumultuous Wednesday as its stock price took a staggering 26% nosedive, plummeting from $3.26 to $2.40. However, the woes for investors didn't end there. In the early premarket hours on Thursday, APVO continued its downward spiral, plunging a further 42% to as low as $1.40. The drastic drop ...
Aptevo Therapeutics Slumps After Discounted Equity Raise
Aptevo Therapeutics Shares Are Trading Lower After the Company Priced Its $4.6 Million Public Offering.
Aptevo Therapeutics Shares Are Trading Lower After the Company Priced Its $4.6 Million Public Offering.
12 Health Care Stocks Moving In Thursday's Pre-Market Session
GainersEliem Therapeutics (NASDAQ:ELYM) stock moved upwards by 51.6% to $4.05 during Thursday's pre-market session. The market value of their outstanding shares is at $112.2 million. Rallybio (NASDAQ:
Aptevo Therapeutics Priced Its Public Offering Of 3.4M Shares And Warrants To Purchase Up To 6.8M Shares At $1.35/Share And Associated Common Warrant, With Gross Proceeds Of $4.6M
Aptevo Therapeutics Priced Its Public Offering Of 3.4M Shares And Warrants To Purchase Up To 6.8M Shares At $1.35/Share And Associated Common Warrant, With Gross Proceeds Of $4.6M
Top Premarket Decliners
Aptevo Therapeutics (APVO) shares slumped 26% Thursday premarket, extending Wednesday's losses. United Homes Group (UHG) shares retreated 15% following a 2.1% drop in the previous session. SolarBank (
Analysis
Price Target
No Data
